Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Seamless Therapeutics: The company raised $1.1 billion of venture funding from Eli Lilly on January 30, 2026. The company is a developer of a gene editing technology used to enable...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions OpenEvidence: The company raised $250 million of Series D venture funding in a deal led by Thrive Capital and DST Global on January 21, 2026, putting the company’s pre-money...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Inquis Medical: The company raised $75 million of Series C venture funding from undisclosed investors on January 12, 2026, putting the company’s pre-money valuation at $300...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Parabilis Medicines: The company raised $305 million of Series F venture funding in a deal led by RA Capital Management, Janus Henderson Investors and Fidelity Management &...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Mediar Therapeutics: The company raised $37.8 million of Series B venture funding from undisclosed investors on December 23, 2025, putting the company’s pre-money valuation at...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Impulse Dynamics: The company raised $158 million of venture funding from Redmile Group, Sands Capital and Perceptive Advisors on December 10, 2025. Alger, Braidwell and other...
